CD8A and neoplasm: Here, by using Cd4–/– and Cd8–/– recipient mice, we demonstrated that the adoptively transferred tumor antigen-specific CD4+ T cells can still exert potent anti-tumor effects even in the absence of endogenous CD4+/CD8+ T cells, which were further confirmed with the treatment of CD8+/CD4+ T depletion antibodies.